The global pharmacovigilance and drug safety software market size was valued at USD 8.5 billion in 2024, driven by increased focus on reducing the potential side effects of drugs across the globe. The market size is anticipated to grow at a CAGR of 9.0% during the forecast period of 2024-2032 to achieve a value of USD 18.4 billion by 2032.